<DOC>
	<DOCNO>NCT00796289</DOCNO>
	<brief_summary>The primary objective study determine safety efficacy pulsatile GnRH deliver iontophoretic patch ( Lutrepatch ) induction ovulation woman anovulatory/ oligoovulatory infertility , compare placebo reference treatment clomiphene citrate .</brief_summary>
	<brief_title>Study Assess Efficacy Safety Three Dosage Strengths Pulsatile GnRH Delivered From Iontophoretic Patch Compared Oral Treatment With Clomiphene Placebo Infertile Females</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1 . Females age 18 38 year 2 . Desire become pregnant 3 . Infertile due ovulatory dysfunction describe : Unable conceive least 1 year Anovulatory ( define 4 few menstrual cycle per year ) Oligoovulatory ( define menstrual cycle frequency &gt; 45 day ) 1 . Requires donor oocyte sperm 2 . Two fail ( defined biochemical pregnancy achieve ) gonadotropin fertility treatment cycle previous gonadotropin success , two fail subsequent cycle 3 . Use insulinsensitizing drug ( e.g. , Metformin ) within 1 month prior progesterone challenge</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>anovulatory/oligoovulatory infertility</keyword>
</DOC>